Evidence map›Paper›PMID 33762978›Full record

ArticleFrontiers in psychiatry2021

Association Between

Hiroshi Komatsu, Hikaru Takeuchi, Chiaki Ono, Zhiqian Yu, Yoshie Kikuchi, Yoshihisa Kakuto, Shunichi Funakoshi, Takashi Ono, Ryuta Kawashima, Yasuyuki Taki and 1 more

Open access · goldAbstract read
PubMed Full text at PMC Publisher
In one paragraph

Article in Frontiers in psychiatry, 2021. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.

0numbers the graph read from it
0cells of the map it votes in
1citing papers in PubMed
0.1field-weighted citation impact, top 71% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

1 citing paper in PubMed, 2 citations in OpenAlex.

  1. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

11 authors at 4 institutions in 1 country.

Hiroshi KomatsuDepartment of Psychiatry, Tohoku University Hospital, Sendai, Japan.
Hikaru TakeuchiDivision of Developmental Cognitive Neuroscience, Institute of Development, Aging and Cancer, Tohoku University, Sendai, Japan.
Chiaki OnoDepartment of Disaster Psychiatry, International Research Institute of Disaster Science, Tohoku University, Sendai, Japan.
Zhiqian YuDepartment of Disaster Psychiatry, International Research Institute of Disaster Science, Tohoku University, Sendai, Japan.
Yoshie KikuchiDepartment of Disaster Psychiatry, International Research Institute of Disaster Science, Tohoku University, Sendai, Japan.
Yoshihisa KakutoMiyagi Psychiatric Center, Natori, Japan.
Shunichi FunakoshiMiyagi Psychiatric Center, Natori, Japan.
Takashi OnoMiyagi Psychiatric Center, Natori, Japan.
Ryuta KawashimaDivision of Developmental Cognitive Neuroscience, Institute of Development, Aging and Cancer, Tohoku University, Sendai, Japan.
Yasuyuki TakiDivision of Developmental Cognitive Neuroscience, Institute of Development, Aging and Cancer, Tohoku University, Sendai, Japan.
Hiroaki TomitaDepartment of Psychiatry, Tohoku University Hospital, Sendai, Japan.
Tohoku University · JPMiyagi Prefectural Hospital Organization · JPTohoku University Hospital · JPTohoku Medical Megabank Organization · JP

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Recent evidence has indicated that the disruption of oligodendrocytes may be involved in the pathogenesis of depression. Genetic factors are likely to affect trait factors, such as characteristics, rather than state factors, such as depressive symptoms. Previously, a negative self-schema had been proposed as the major characteristic of constructing trait factors underlying susceptibility to depression. Thus, the association between a negative self-schema and the functional single nucleotide polymorphism (SNP) rs1059004 in the

Indexed as

depressive symptomsnegative self-schemaOLIG2oligodendrocytesingle nucleotide polymorphism

Identifiers

PMID33762978
PMCPMC7983671
OpenAlexW3134407400

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.